Veronica Ashton

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Venues

Journal of clinical hypertension (Greenwich, Conn.)

Current medical research and opinion

Journal of thrombosis and thrombolysis

American journal of cardiovascular drugs : drugs, devices, and other interventions

Janssen Scientific Affairs LLC

Rutgers University New Brunswick (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Janssen Scientific Affairs LLC Jun 08 2015

United States

Associate Director :: Real World Value & Evidence

Merck and Co Inc

United States

Project Manager :: Global Health Outcomes

Merck and Co Inc

United States

Research Fellow :: Global Health Outcomes

Rutgers School of Public Health

United States

Program Support Specialist :: Epidemiology

Rutgers School of Public Health

United States

Project Coordinator :: Epidemiology

Education History

Rutgers University New Brunswick

United States

BSC :: Biological Sciences

Publications

George L Bakris, Pei Paul Lin, Chang Xu, Cindy Chen, Veronica Ashton, Mukul Singhal
Prediction of cardiovascular and renal risk among patients with apparent treatment-resistant hypertension in the United States using machine learning methods. Journal of clinical hypertension (Greenwich, Conn.) (2024)
George L Bakris, Pei Paul Lin, Chang Xu, Cindy Chen, Veronica Ashton, Mukul Singhal
Prediction of cardiovascular and renal risk among patients with apparent treatment-resistant hypertension in the United States using machine learning methods. Journal of clinical hypertension (Greenwich, Conn.) 26 (5) (2024)
George L Bakris, Pei Paul Lin, Chang Xu, Cindy Chen, Veronica Ashton, Mukul Singhal
Prediction of cardiovascular and renal risk among patients with apparent treatment-resistant hypertension in the United States using machine learning methods. Journal of clinical hypertension (Greenwich, Conn.) 26 (5) (2024)
George L Bakris, Pei Paul Lin, Chang Xu, Cindy Chen, Veronica Ashton, Mukul Singhal
Prediction of cardiovascular and renal risk among patients with apparent treatment-resistant hypertension in the United States using machine learning methods. Journal of clinical hypertension (Greenwich, Conn.) 26 (5) (2024)
George L Bakris, Cindy Chen, Alicia K Campbell, Veronica Ashton, Lloyd Haskell, Mukul Singhal
Association of uncontrolled blood pressure in apparent treatment-resistant hypertension with increased risk of major adverse cardiovascular events plus. Journal of clinical hypertension (Greenwich, Conn.) (2023)
Jeffrey S Berger, François Laliberté, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Veronica Ashton
Effectiveness, safety, and healthcare costs associated with rivaroxaban versus warfarin among venous thromboembolism patients with obesity: a real-world study in the United States. Journal of thrombosis and thrombolysis 54 (3) (2022)
Jeffrey S Berger, François Laliberté, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Veronica Ashton
Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US population. Journal of medical economics 24 (1) (2021)
Jeffrey S Berger, François Laliberté, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Veronica Ashton
Real-world effectiveness and safety of rivaroxaban versus warfarin among non-valvular atrial fibrillation patients with obesity in a US population. Current medical research and opinion 37 (6) (2021)
Craig I Coleman, Thomas J Bunz, Veronica Ashton
Adherence and persistence to rivaroxaban in non-valvular atrial fibrillation patients receiving 30- or 90-day supply prescription fills. Current medical research and opinion (2021)
Veronica Ashton, Lana Mudarris, Kenneth Todd Moore
The Pharmacology, Efficacy, and Safety of Rivaroxaban in Obese Patient Populations. American journal of cardiovascular drugs : drugs, devices, and other interventions 21 (3) (2021)
François Laliberté, Veronica Ashton, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Jeffrey S Berger
Economic burden of rivaroxaban and warfarin among nonvalvular atrial fibrillation patients with obesity and polypharmacy. Journal of comparative effectiveness research 10 (16) (2021)
Jeffrey S Berger, François Laliberté, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Veronica Ashton
Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US). Advances in therapy 38 (7) (2021)

Veronica Ashton.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Veronica Ashton